Beijing Macro-Union pharmaceutical Co., Ltd. (BMUP) was founded by Macrolink Group (holds 51%) and Peking Union Medical College Hospital(PUMCH, holds 49%) in 2007, registered capital 42 million RMB. Its predecessor was the allergen manufacturing laboratory of PUMCH with the history of 60 years. BMUP are devoted into developing all kinds of medicines for desensitization treatment and detection kits of in vivo & in vitro based on the professional team and multiple intellectual properties. BMUP is a leading enterprise which can provide a whole solution in the field of allergy (include allergen raw materials and end products, detection kits, vaccine and preventive health care products etc.
